Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EXP | BLSH |
|---|---|---|
| Price | $169.82 | $34.35 |
| Change today | ▼ 0.90% | ▲ 0.35% |
| Market cap | $5.21B | $5.21B |
| Return, 3 months | -20.2% | +33.3% |
| Return, year to date | -17.5% | -9.3% |
| Return, 1 year | -27.7% | -50.1% |
| P/E (TTM) | 13.4 | -3.7 |
| P/B | 3.5 | 2.2 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.59% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 30 | 49 |
| 30-day volatility | 20.0% | 73.2% |
| Max drawdown, 1 year | -29.4% | -68.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
